Brief: Cipher Pharma Announces Canadian Launch of OZANEX
08/01/2018 12:32
Jan 8 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO :
* CIPHER PHARMACEUTICALS ANNOUNCES CANADIAN LAUNCH OF
OZANEX
(OZENOXACIN CREAM 1%), A NOVEL TOPICAL ANTIBIOTIC
Source text for Eikon: ID:nCNWTKH1la
Further company coverage: CPH.TO
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Cipher Pharmaceuticals
See all newsBrief: Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
Canada's Cipher Pharma Q2 revenue falls on lower Natroba sales amid reduced Medicaid coverage
Canada Research Roundup: Altius Minerals, Cipher Pharmaceuticals, Suncor Energy
Canada's Cipher Pharmaceuticals Q1 net income jumps 135% on lower costs
Brief: Cipher Pharmaceuticals Q1 Net Income USD 6.163 Million